Announcements Trials
Browse Landscape

Phase

Phase 2/3 3Phase NA 1Phase 3 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 3Lymphoid 3

Conditions

Neoplasms, Plasma Cell 3Neoplasms 3Lymphoma 3Leukemia 3Infections 3Lymphoma, Non-Hodgkin 1Hematologic Neoplasms 1Agammaglobulinemia 1

Interventions

Dexamethasone 8daratumumab 5Lenalidomide 5Bortezomib 5Trimethoprim, Sulfamethoxazole Drug Combination 4Thalidomide 4Cyclophosphamide 4gamma-Globulins 3Ciprofloxacin 3carfilzomib 2Melphalan 2Immunoglobulins, Intravenous 2Calcium Dobesilate 2Amoxicillin-Potassium Clavulanate Combination 2trametinib 1tanespimycin 1pomalidomide 1pazopanib 1fludarabine 1dabrafenib 1cobimetinib 1Whole-Body Irradiation 1Vemurafenib 1Stem Cell Transplantation 1Rivaroxaban 1Radiotherapy 1Radiation 1Pharmaceutical Preparations 1Mesna 1MAGEA3 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Ciprofloxacin × Plasma cell × Clear all
NCT07202052 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms, Plasma Cell

NCT07202091 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Neoplasms, Neoplasms, Plasma Cell

NCT05678621 2024-04-19

RATIONALISE

Monash University

Phase 2/3 Recruiting
300 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Agammaglobulinemia, Infections, Leukemia, Lymphoma, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡